Contract Win with U.S. Government Research Agency
07 November 2012
Instem plc
("Instem", the "Company" or the "Group")
Contract Win with U.S. Government Research Agency
Provantis Preclinical Software Chosen to Advance Key NIAID Research Programs
Instem plc (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, announces today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has selected Instem’s integrated Provantis® preclinical software suite to help advance research programs against infectious, immunologic, and allergic diseases.
Provantis is being deployed within U.S. based laboratories where NIAID conducts basic and applied research activities aimed at improving public health in the United States and around the world.
Phil Reason, CEO of Instem plc, commented: “It is a great affirmation of Instem’s products that another US Government Agency has selected our software. The award of this contract is very exciting for Instem as the NIH invests over $30.9 billion annually in medical research and Instem has been actively targeting institutions and projects directly or indirectly funded from this budget.”
For further information, please contact:
| Instem plc | www.instem.com |
| Phil Reason, CEO | +44 (0) 1785 825600 |
| Nigel Goldsmith, CFO | |
| N+1 Singer (Nominated Adviser & Broker) | +44 (0) 20 7496 3000 |
| Richard Lindley | |
| Nick Owen | |
| James White | |
| Wallbrook Financial PR | Tel: +44 (0) 20 7933 8000 |
| Paul Cornelius | or instem@walbrookpr.com |
| Sam Allen | |
| Helen Cresswell | |
| Paul Whittington |
About Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidlyexpanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 450 clients through full service offices in the United States, United Kingdom and China with additional locations in Japan and India.
To learn more about Instem solutions and its mission, please visit instem.com.